MDK is known to harbor p53 binding sites, where binding of the appropriate protein activates the transcription of MDK in gliomas, while knockdown of p53 downregulates the expression of mRNA and protein levels of MDK (20). This evidence concerns the gene TP53 and central nervous system cancer.